NPF CSMO, Dr. Guy Eakin, sat down with Dr. Henry Lim, Senior Vice President of Academic Programs at Henry Ford Health Centers and internationally recognized dermatology expert, to discuss clinic and home phototherapy. Listen now to learn more about how to access it for your patients, and how to manage challenges with adherence. This episode was brought to you today by Phothera, a leader in phototherapy solutions.

How do you define on-treatment remission? As Dr. April Armstrong, M.D., MPH, Professor and Chief of Dermatology at the University of California, Los Angeles, and Dr. Wilson Liao, M.D., Professor and Associate Vice Chair of Research in the University of California, San Fransico Department of Dermatology, that question was not easily answered.

Listen to learn about the new definition, how the working group arrived at it, and how it will benefit patients, payers, and other stakeholders.

Hear from Dr. Mark Lebwohl, MD, Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai and Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology, and Dr. Jason Hawkes, M.D., M.S., co-owner, CSO, and principal investigator at the Oregon Medical Research Center, discuss the intersection of obesity, psoriasis, and GLP-1s.

This podcast was brought to you by Lilly.

Dr. Amy Paller, pediatric dermatologist and clinical researcher at Northwestern Feinberg School of Medicine, and Dr. Ronald Prussick, MD, dermatologist at the Washington Dermatology Center and Vice Chair of the NPF Medical Board, discuss psoriasis and eczema comorbidities in pediatric and adult patients. This podcast is presented in collaboration with the National Eczema Association.

This podcast is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $375,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Dr. Bruce Strober, MD, PhD, dermatologist and JPPA Editor-in-Chief, and Guy Eakin, PhD, Chief Science and Medical Officer at the NPF discuss the Journal of Psoriasis and Psoriatic Arthritis path to indexing and what it means for the research community moving forward. This podcast is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $375,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Hear dermatologists Dr. Kristina Duffin, MD, MS, Professor and Chair of the Department of Dermatology at the University of Utah and Dr. Joel Gelfand, MD, MSCE, FAAD, Director, Psoriasis & Phototherapy Treatment Center at Penn, discuss the Light Treatment Effectiveness (LITE) Study and the data presented at the 2024 AAD Annual Meeting.

The LITE Study is funded with support from the Patient-Centered Outcomes Research Institute (PCORI), an independent research institute authorized by Congress to fund comparative clinical effectiveness research that engages patients and other stakeholders in the research process. This study also benefited from the Daavlin Company's contribution of the phototherapy machines on behalf of this study.

This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Hear gastroenterologist Dr. Lisa Malter, Professor at the Department of Medicine at NYU Grossman School of Medicine, discuss the intersection between psoriasis and IBD.

This program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Hear rheumatologist Dr. Lihi Eder from the University of Toronto discuss diagnostic biomarkers and the use of imaging to diagnose psoriatic arthritis.

This program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

This program is supported by educational grants from AbbVie and Novartis.

Hear Dr. Ron Prussick, from the Washington Dermatology Center, discuss the importance of diet in patients living with psoriasis.

This program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

This program is supported by educational grants from AbbVie and Novartis.

Can accountability and gamification improve treatment adherence? Hear Dr. Steven Feldman, Professor at Wake Forest University School of Medicine, discuss this and more.

This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

This program is supported by educational grants from AbbVie and Novartis.